Loading insider details...
Latest Form 4 (Nov 5, 2026): Exercise/Conversion of 1,402 MNPR shares, $42.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 5, 2026 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 1,402 | $42.1K |
| Aug 28, 2026 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 1,402 | $42.1K |
| Dec 8, 2025 | Monopar Therapeutics (MNPR) | Grant/Award | 2,924 | n/a |
| Mar 8, 2025 | Monopar Therapeutics (MNPR) | Grant/Award | 11,365 | n/a |
| Jan 4, 2024 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 2,533 | n/a |
| Oct 3, 2023 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 2,533 | n/a |
| Jul 3, 2023 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 2,534 | n/a |
| Apr 4, 2023 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 2,533 | n/a |
| Feb 3, 2023 | Monopar Therapeutics (MNPR) | Grant/Award | 13,930 | n/a |
| Jan 3, 2023 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 2,859 | n/a |